4//SEC Filing
GOODMAN COREY S 4
Accession 0001567619-22-012695
CIK 0001851194other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 6:22 PM ET
Size
17.4 KB
Accession
0001567619-22-012695
Insider Transaction Report
Form 4
GOODMAN COREY S
10% OwnerOther
Transactions
- Award
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total(indirect: See footnote)Exercise: $16.54Exp: 2032-06-09→ Common Stock (13,301 underlying) - Award
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total(indirect: See footnote)Exercise: $16.54Exp: 2032-06-09→ Common Stock (13,301 underlying)
venBio Global Strategic Fund III, L.P.
10% OwnerOther
Transactions
- Award
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total(indirect: See footnote)Exercise: $16.54Exp: 2032-06-09→ Common Stock (13,301 underlying) - Award
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total(indirect: See footnote)Exercise: $16.54Exp: 2032-06-09→ Common Stock (13,301 underlying)
VENBIO GLOBAL STRATEGIC GP III, L.P.
10% OwnerOther
Transactions
- Award
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total(indirect: See footnote)Exercise: $16.54Exp: 2032-06-09→ Common Stock (13,301 underlying) - Award
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total(indirect: See footnote)Exercise: $16.54Exp: 2032-06-09→ Common Stock (13,301 underlying)
VENBIO GLOBAL STRATEGIC GP III, LTD
10% OwnerOther
Transactions
- Award
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total(indirect: See footnote)Exercise: $16.54Exp: 2032-06-09→ Common Stock (13,301 underlying) - Award
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total(indirect: See footnote)Exercise: $16.54Exp: 2032-06-09→ Common Stock (13,301 underlying)
Adelman Robert J
10% OwnerOther
Transactions
- Award
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total(indirect: See footnote)Exercise: $16.54Exp: 2032-06-09→ Common Stock (13,301 underlying) - Award
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total(indirect: See footnote)Exercise: $16.54Exp: 2032-06-09→ Common Stock (13,301 underlying)
Footnotes (4)
- [F1]The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or, (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date the option was granted, in each case, subject to the relevant director (Dr. Royston and Dr. Gaster) continuing to be Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable vesting date.
- [F2]Represents options awarded to Aaron Royston, a director and partner of venBio Global Strategic GP III, Ltd. ("venBio Ltd"), pursuant to the annual equity grant under the Issuer's non-employee director compensation policy. These options are held for the benefit of venBio Global Strategic Fund III, L.P. ("venBio III"). Pursuant to policies of venBio Partners, the manager of venBio III, with respect to director compensation, upon the exercise of these options and sale of the underlying securities, the proceeds will be remitted to venBio III. Dr. Royston disclaims beneficial ownership over the shares underlying the options held for the benefit of venBio III except to the extent of his pecuniary interest therein.
- [F3]Represents options awarded to Richard Gaster, a partner of venBio Global Strategic GP III, L.P. ("venBio GP"), pursuant to the annual equity grant under the Issuer's non-employee director compensation policy. These options are held for the benefit of venBio III. Pursuant to policies of venBio Partners, the manager of venBio III, with respect to director compensation, upon the exercise of these options and sale of the underlying securities, the proceeds will be remitted to venBio III. Dr. Gaster disclaims beneficial ownership over the shares underlying the options held for the benefit of venBio III.
- [F4]venBio GP is the sole general partner of venBio III. venBio Ltd. is the sole general partner of venBio GP. Dr. Royston, Robert Adelman and Corey Goodman (collectively, the "Directors") are each a director of venBio Ltd and may be deemed to share voting and dispositive power over the shares held by venBio III. Each of the Directors, together with venBio Ltd and venBio GP, disclaims beneficial ownership over the shares underlying the options held for the benefit of venBio III except to the extent of their pecuniary interest therein.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001278411
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 6:22 PM ET
- Size
- 17.4 KB